Firm Practice Areas/Practice Groups

Pharmaceutical
Biotechnology
Chemical

Experience

Post-doctoral researcher, NIAAA, (NIH) – 1995
Technical Advisor, Greenblum and Bernstein, P.L.C. – 1996-2000
Student Associate, Finnegan Henderson – 2000-2001
Patent Attorney, Finnegan Henderson – 2001-2003
Patent Attorney, Calfee, Halter and Griswold – 2003-2005
Patent Attorney, Greenblum and Bernstein, P.L.C. – 2006-Present

Notable

Supervises patent preparation and prosecution in the pharmaceuticals, biotechnology and chemical areas.
Travels to Japan regularly.

Representative Publications

Myers-Payne, S.C., (2010). “Will Bilski put limits on pharmaceutical patents?” 7 Journal of Generic Medicines 205-10.

Greenblum, N., Fink, M., Roylance, S., Pejic, P.B., Myers-Payne, S.C., Braier, P., (2008). “Generic Drugs in a Changing Intellectual Property Landscape.” The Pharmaceutical Regulatory Process, Second Edition, pps. 143-180, Ira R. Berry and Robert P. Martin, eds., Informa Health Care.

Myers-Payne, S.C., (2006). “A missed opportunity — Labcorp v. Metabolite Laboratories.” 4-1 Journal of Generic Medicines 59-63.

Myers-Payne, S.C., (Spring 2004). Determining entitlement to a date of invention: Chen v. Bouchard. Ohio State Bar Association, Intellectual Property Section, 12(2).

Myers-Payne, S.C., Hubbell, T., Pu, L., Schnutgen, F., Borchers, T., Wood, W.G., Spener, F., and Schroeder, F. (1996). Isolation and characterization of two fatty acid binding proteins from mouse brain. J. Neurochem., 66(4), 1648-1656.

Myers-Payne, S.C., Fontaine, R.N., Loeffler, A., Pu, L., Rao, A.M., Kier, A.B., Wood, W.G., and Schroeder, F. (1996). Effects of chronic ethanol consumption on sterol transfer proteins in mouse brain. J. Neurochem, 66(1), 313-320.
Myers-Payne, S.C., Hui, D.Y., Brockman, H.L., and Schroeder, F. (1995). Cholesterol esterase: a cholesterol transfer protein. Biochemistry, 34(12), 3942-3947.

Bar Admissions

1998, USPTO
2001, Virginia
2002, District of Columbia